Login / Signup

Food and Drug Administration Sets Stage for Approval of First Duchenne Muscular Dystrophy Gene Therapy.

Alex Philippidis
Published in: Human gene therapy (2023)
Keyphrases
  • drug administration
  • duchenne muscular dystrophy
  • gene therapy
  • human health
  • muscular dystrophy
  • risk assessment
  • climate change